Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
Year-over-year debt growth rate
Latest
0.90%
↓ 97% vs avg
Percentile
P79
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
34.31%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.90% |
| Q3 2025 | -3.63% |
| Q2 2025 | 101.94% |
| Q1 2025 | 355.49% |
| Q4 2024 | -22.18% |
| Q3 2024 | -17.86% |
| Q2 2024 | -14.63% |
| Q1 2024 | -12.54% |
| Q4 2023 | -10.95% |
| Q3 2023 | -9.69% |
| Q2 2023 | -8.49% |
| Q1 2023 | -7.68% |
| Q4 2022 | -7.00% |
| Q3 2022 | -6.42% |
| Q2 2022 | -5.78% |
| Q1 2022 | -5.36% |
| Q4 2021 | -4.99% |
| Q3 2021 | -19.44% |
| Q2 2021 | -16.69% |
| Q1 2021 | -2.97% |
| Q4 2020 | -2.83% |
| Q3 2020 | -2.70% |
| Q2 2020 | -1.52% |
| Q1 2020 | 8.92% |
| Q4 2019 | 648.92% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | -96.81% |
| Q2 2017 | 167.74% |
| Q1 2017 | 35.50% |
| Q4 2016 | 121.85% |
| Q3 2016 | 289.07% |
| Q2 2016 | -77.62% |
| Q1 2016 | 0.00% |